Managed for ICORE Healthcare by
Atlantic Information Services, Inc.
Register today for our complimentary 90-minute webinar!
Magellan Pharmacy Solutions’ 2012 Medical Pharmacy & Oncology Trend Report provides the only source for trends and benchmarking statistics for injectables paid under the medical benefit.
Join us for this complimentary webinar and hear Michael Waterbury, President of ICORE, discuss the report's key findings.
Did you know that Lucentis, an injectable therapy for treating Macular Degeneration, is among the top 5 for drug-spend per million lives covered under the medical benefit? In fact, specialty drugs now account for 25%1 of total spend. And this figure is expected to grow to over 30% by 20162, with approximately half the specialty spend occurring on the medical benefit3. Do you have the right tools and strategies to manage this spend?
Sign up today to gain valuable insights from the 2012 Medical Pharmacy & Oncology Trend Report including:
1. National Sales Perspectives.” IMS Institute for Healthcare Informatics. December 2011.
2. Prime Therapeutics 2012 Prime Drug Trend Insights.
3. ESI 2012 Drug Trend Report.
Michael H. Waterbury
President, ICORE Healthcare
Michael Waterbury serves as President of ICORE Healthcare, Magellan’s specialty pharmacy business unit. Under his leadership ICORE is continuing to redefine how America’s health plans manage complex specialty pharmaceuticals to ensure clinical excellence, while minimizing costs in one of the fastest-growing areas of healthcare spending. Previously, Michael served as senior vice president, Medical Pharmacy Solution for Magellan’s ICORE Healthcare. In this role, he was responsible for the medical pharmacy management division and the oversight of the successful oncology model, that has served as the foundation for managing programs for other complex diseases, such as rheumatoid arthritis, Crohn’s and psoriasis.
Prior to his role at Magellan, Michael served as executive vice president, healthcare services for United Healthcare/Oxford Health Plans. In this role, he managed the New York network and was primarily responsible for hospital and physician contracting for commercial, Medicare and Medicaid lines of business. Michael also managed the health care initiatives team and led key integration projects for network and contracting management.
While at Oxford Health Plans, Michael served as vice president, healthcare services and managed a pharmacy benefit manager contract for 1.4 million members. He also implemented Oxford’s oncology management and clinical program including physician injectable drug reimbursement strategies, network management and clinical programs.
Michael received his bachelor of arts in business administration from the University of Richmond.
Moderator: Angela Maas, Managing Editor of Atlantic Information Services, Inc.'s Specialty Pharmacy News
A concluding 30-minute Q&A session will give you a chance to pose questions to Mr. Waterbury.
WHAT IS A WEBINAR?
All you need to access our Webinar is a phone line and access to the Internet – no downloads are required. Our Webinars allow you to view the presentations on the Web as a slideshow, while listening to the audio presentation on the phone. The presentation is followed by a 30-minute Q&A with the speaker(s). You can invite all your colleagues to gather in a conference room with one computer and a speakerphone to share the experience.
MAC and PC COMPATIBLE
Our Webinars work equally well on PCs and Macs.
Register above (or call 800-521-4323 to register).
When you register, you will receive a confirmation by email from AISconferences@aishealth.com, with a toll-free number, password and Web link that you will use to connect to the Webinar.
There is no limit on the number of participants from your office, but each registration covers only one log-in. Additional log-ins require additional registrations.